FDA Inspection 1246225 — Beata Gawdis Wojnarska
The FDA completed an inspection of Beata Gawdis Wojnarska on Aug 2, 2024 in Szczecin. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 2, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Szczecin (Poland)
Additional Details
Clinical Investigator (CI)